Croda International Plc (LON:CRDA – Get Free Report) insider Stephen Oxley acquired 4 shares of the stock in a transaction on Tuesday, November 10th. The stock was bought at an average price of GBX 3,625 per share, for a total transaction of £145.
Stephen Oxley also recently made the following trade(s):
- On Monday, October 12th, Stephen Oxley acquired 5 shares of Croda International stock. The shares were purchased at an average cost of GBX 3,388 per share, for a total transaction of £169.40.
- On Thursday, September 10th, Stephen Oxley bought 4 shares of Croda International stock. The shares were purchased at an average cost of GBX 3,218 per share, with a total value of £128.72.
Croda International Price Performance
LON:CRDA opened at GBX 3,762 on Friday. The company has a debt-to-equity ratio of 36.06, a current ratio of 2.57 and a quick ratio of 2.25. The firm has a market cap of £5.24 billion, a price-to-earnings ratio of 66.12, a price-to-earnings-growth ratio of 1.40 and a beta of 0.92. The company has a 50 day moving average price of GBX 3,442.43 and a 200-day moving average price of GBX 3,101.13. Croda International Plc has a 1-year low of GBX 2,488 and a 1-year high of GBX 3,784.
Wall Street Analysts Forecast Growth
CRDA has been the topic of several analyst reports. Deutsche Bank restated a “hold” rating and set a GBX 3,300 price target on shares of Croda International in a research report on Friday, November 6th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 4,000 price objective on shares of Croda International in a research report on Thursday, November 5th. Berenberg Bank increased their target price on shares of Croda International from GBX 3,600 to GBX 4,400 and gave the stock a “buy” rating in a research note on Friday, November 6th. Finally, Citigroup raised their target price on Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Croda International presently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,650.
Get Our Latest Research Report on Croda International
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
